BioXcel Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference

December 22, 2022

https://www.globenewswire.com/news-release/2022/12/22/2578481/0/en/BioXcel-Therapeutics-to-Present-at-41st-Annual-J-P-Morgan-Healthcare-Conference.html

NEW HAVEN, Conn., Dec. 22, 2022 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq:BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that Vimal Mehta, Ph.D., CEO of BioXcel Therapeutics, will present corporate updates and anticipated milestones for 2023 at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 11, 2023 at 9:45 a.m. PST.

Read more at globenewswire.com

Related news for (BTAI)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.